211
First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients
Condition(s):HemophiliaLast Updated:May 5, 2021Terminated
First in Human: 7227 Clinical Trials, Page 22 of 723
Hide Studies Not Open or Pending
212
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Condition(s):Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia; High-grade B-cell Lymphoma; Primary Mediastinal Large B-cell LymphomaLast Updated:July 6, 2022Recruiting
213
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Condition(s):PIK3CA Mutation; Solid Tumor, Adult; HER2-negative Breast Cancer; Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; Unresectable Solid TumorLast Updated:November 21, 2022Recruiting
214
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211
Condition(s):ObesityLast Updated:May 1, 2018Unknown status
215
First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94
Condition(s):Anemia; Chronic Diseases; InflammationLast Updated:January 25, 2016Completed
216
A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers
Condition(s):Traumatic Brain Injury (TBI)Last Updated:September 24, 2021Recruiting
217
A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects
Condition(s):PharmacologyLast Updated:March 21, 2022Completed
218
Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy
Condition(s):Coronary Artery DiseaseLast Updated:January 13, 2017Completed
219
First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:October 27, 2016Completed
220
First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector
Condition(s):Metastatic Cancer; Epithelial TumorLast Updated:January 18, 2023Recruiting